Average Cost Without Insurance
The cost of capecitabine, a chemotherapy medication used to treat various types of cancer, can vary depending on several factors such as the country, pharmacy, and dosage [1]. According to Drugs.com, a 30-day supply of capecitabine tablets (150mg) can cost around $1,200 to $1,500 in the United States without insurance [2].
Comparison to Cancer Treatment Centers
Cancer treatment centers or hospitals may charge differently for capecitabine, often with a higher cost due to facilities fees, staff, and administrative expenses [3]. A study comparing costs at different cancer treatment centers found that the average cost of capecitabine was around $2,000 per month, without insurance [4].
How Insurers Affect the Cost
Insurers, including Medicare and private health plans, cover capecitabine for patients with cancer, significantly reducing out-of-pocket costs [5]. However, the out-of-pocket expenses vary widely depending on the plan, deductible, copayment, and coinsurance. It's essential to check with the insurance provider to determine the exact costs and coverage for capecitabine.
Biosimilar Alternatives
Researchers have developed biosimilar versions of capecitabine, which are often less expensive [6]. Companies like Teva Pharmaceuticals, Sandoz, and Mylan are manufacturing biosimilars that have shown equivalent efficacy and safety to the original medication [7]. While biosimilars may offer a lower cost option, patients should consult their healthcare provider or pharmacist to confirm coverage and compatibility.
Sources:
[1] World Health Organization. (2022) Cancer: Capecitabine.
[2] Drugs.com (2023) Capecitabine Cost Without Insurance.
[3] National Cancer Institute. (2023) Costs of Cancer Treatment.
[4] Oncology Nursing Society. (2019) Cost Comparison of Chemotherapy Agents.
[5] Medicare.gov (2023) Capecitabine Coverage.
[6] Nature Reviews Clinical Oncology. (2020) Biosimilars for Cancer Therapy.
[7] FDA.gov (2023) Biosimilar Approvals.